About Conferences :

The Obesity Summit-2023 is an international forum to discuss and explore the early detection of obesity as well as its treatment using professional standards and extensive research. The conference's theme, "Techniquies for Obesity Treatment and Metabolic diseases Prevention," draws notable international professionals in medicine from doctors to researchers to general practitioners, as well as student delegates and exhibitors from around the globe. Oral presentations, poster presentations, keynote addresses, seminars, and more will all be included in the conference.

Why to attend the conference:

The OBESITY SUMMIT-2023 is one of the top scientific conferences in the globe, bringing together attendees to discuss cutting-edge research and technologies and to share new insights into improving elder care practises for improving quality health and preventing obesity. Attending a global conference is an opportunity for professional growth and to raise awareness of the status of research today and the obstacles to discovery in the future.

For someone who wants to maintain their clinical education without travelling, webinars are an option. They are interactive services that provide case-based presentations, online reviews, and live chats with prominent opinion leaders that provide useful advice in your everyday practise of science.





  • Business Professionals
  • Students
  • University Professors
  • Doctors
  • Cardiologists
  • Psychiatrists
  • Fitness Professionals
  • Diabetes Educators
  • Scientists
  • Researchers
  • Endocrinologists
  • Yoga Professionals
  • Pharmacist

Market Analysis:

With a CAGR of 5.1%, the obesity management market is anticipated to increase from USD 828.71 million in 2022 to USD 1362.80 million by 2032. The obesity management industry is anticipated to create significant revenue in the next years due to the rapid increase in obesity incidence over the past 20 years.Data Bridge Market Research studies the rate of growth of the market for therapeutics for metabolic disorders throughout the anticipated period of 2022–2029 The market for therapies for metabolic disorders is projected to expand at a CAGR of around 7.50 percent over the aforementioned forecast period. The market was valued at USD 62 billion in 2021, and it was predicted that by 2029, it will be worth USD 110.58 billion. The Data Bridge Market Research team's report on the market.


  • American Association of Clinical Endocrinologists
  • The American Association of Endocrine Surgeons
  • Association of Program Directors in Endocrinology, Diabetes and Metabolism
  • Society for Endocrinology
  • Brazilian Society of Surgical Endocrinology
  • British Society for Paediatric Endocrinology and Diabetes
  • European Society of Endocrinology
  • International Society of Endocrinology
  • Paediatric Endocrine Society
  • Universitys:
  • Harvard University
  • University of Oxford
  • University of Cambridge
  • Johns Hopkins University
  • Stanford University
  • Yale University
  • University of California
  • University of Melbourne

Join Our Newsletter